FDA pushes cancer trials to include more elderly people
From Science by Jennifer Couzin-Frankel
New guidance aims to improve understanding of drug safety, effectiveness in older adults
Older adults make up a hefty proportion of cancer patients but a much smaller slice of clinical trial participants—a long-standing and vexing problem the U.S. Food and Drug Administration (FDA) wants drug companies to tackle.